Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
106 hedge funds and large institutions have $365M invested in Intersect ENT, Inc in 2017 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 28 reducing their positions, and 11 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
82% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 11
53% more call options, than puts
Call options by funds: $2.18M | Put options by funds: $1.42M
48% more capital invested
Capital invested by funds: $247M → $365M (+$118M)
29% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 28
2% more funds holding
Funds holding: 104 → 106 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$23M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$9.35M |
| 3 |
PC
Paulson & Co
New York
|
+$8.97M |
| 4 |
PVI
Pura Vida Investments
New York
|
+$5.43M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
-$6.82M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$5.49M |
| 3 |
Barclays
London,
United Kingdom
|
-$3.97M |
| 4 |
Millennium Management
New York
|
-$3.56M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.12M |
XENT Hedge Fund Activity: Q1 2017 in Review
106 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q1 2017, worth a combined $365M — up 48% from $247M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new XENT positions and 11 closed out — a net gain of 9 holders — while 36 added to existing stakes and 28 trimmed.
The largest buyer was BlackRock, adding an estimated $23M. The largest seller was OppenheimerFunds, exiting entirely with an estimated $6.82M sold.
- 106 institutional investors held Intersect ENT, Inc (XENT) as of Q1 2017, up from 104 in Q4 2016.
- Funds reported $365M of Intersect ENT, Inc stock for Q1 2017, up 48% quarter-over-quarter.
- 20 funds opened new Intersect ENT, Inc positions in Q1 2017 and 11 closed out, a net change of +9 holders.
- The largest Intersect ENT, Inc buyer in Q1 2017 was BlackRock, an estimated $23M added.
- The largest Intersect ENT, Inc seller in Q1 2017 was OppenheimerFunds, an estimated $6.82M sold.
Based on aggregated 13F filings for Q1 2017.